Clinical characteristics and distribution of hepatitis B virus genotypes in Guangxi Zhuang population

World Journal of Gastroenterology

Volumn 11, Issue 41, 2005, Pages 6525-6529

  Huang, Zhong Min ^a   Huang, Qi Wen ^a   Qin, Ya Qin ^a   Huang, Chun He ^a   Qin, Hou Ji ^a   Zhou, Yiao Nan ^a   Xu, Xiang ^a   Lu, Chun Lei ^a  

^a Department of Nephrology   (China)

Author keywords

Chronic hepatitis; Genotype; Hepatitis B virus; Lamivudine; YMDD mutation; Zhuang nationality

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTIC ACID; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; METHIONINE; NUCLEIC ACID; TYROSINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; CHRONIC HEPATITIS; CLASSIFICATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; GENE MUTATION; GENETIC PARAMETERS; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCOSM; NONHUMAN; PATIENT SELECTION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS LOAD;

EID: 31344469689     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i41.6525     Document Type: Article

References (32)

1. Hepatology branch-conference of infectious diseases, parasitic diseases association of Chinese medical association. Schemes of prevention and cure for viral hepatitis. Zhonghua Ganzangbing Zazhi 2000; 8: 324-329
2. Lamivudine Clinical Practice Group. Lamivudine treatment consensus from relative experts in 2003. Zhonghua Ganzangbing Zazhi 2003; 8: 497-499
3. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003; 46: 329-338
4. Kato H, Gish RG, Bzowej N, Newsom M, Sugauchi F, Tanaka Y, Kato T, Orito E, Usuda S, Ueda R, Miyakawa Y, Mizokami M. Eight genotypes (A-H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics. J Med Virol 2004; 73: 516-521
5. Yuen MF, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan HJ, Wong DK, Sum SM, Lai CL. Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 2004; 41: 119-125
6. Sallam TA, William Tong CY. African links and hepatitis B virus genotypes in the Republic of Yemen. J Med Virol 2004; 73: 23-28
7. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS. Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 2003; 125: 444-451
8. Lee CM, Chen CH, Lu SN, Tung HD, Chou WJ, Wang JH, Chen TM, Hung CH, Huang CC, Chen WJ. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan. Scand J Gastroenterol 2003; 38: 95-101
9. Zhu B, Luo K, Hu Z. Establishment of a method for classification of HBV genome and it's application Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 1999; 13: 309-313
10. Xia G, Nainan OV, Jia Z. Characterization and distribution of hepatitis B virus genotypes and subtypes in 4 provinces of China Zhonghua Liu Xing Bing Xue Za Zhi 2001; 22: 348-351
11. Ge XM, Li DY, Fang ZL, Huang GY, Jiang SQ, Pan HD, Du Y, Wang CY, Ding X, Masashi M. Distribution of hepatitis B virus genotypes and its clinical significance in Guangxi Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003; 17: 174-179
12. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, Kimura Y, Ueda R, Butterworth LA, Cooksley WG. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol 2001; 82: 883-892
13. Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol 2001; 34: 584-586
14. Yan MH, Zhang C, Ling Q, Zhou RF. Detection of YMDD motif mutations in lamivudine-untreated patients with chronic hepatitis B Zhonghua Gan Zang Bing Za Zhi 2003; 11: 430-431
15. Zhang XH, Zhang YX, Sun LR, Wen Q, Zhou LQ, Fan GX, Zhang X, Yang DG. Study of gene chips in the detection of YMDD mutations in the region of HBV polymeras Zhonghua Yi Xue Za Zhi 2003; 83: 459-462
16. Matsuda M, Suzuki F, Suzuki Y, Tsubota A, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Satoh J, Takagi K, Kobayashi M, Ikeda K, Kumada H. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine. J Gastroenterol 2004; 39: 34-40
17. Kobayashi S. Clinical characteristics of asymptomatic hepatitis B virus carriers with YMDD mutant not treated with lamivudine. Kurume Med J 2003; 50: 87-90
18. Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999; 6: 299-304
19. Duong TN, Horiike N, Michitaka K, Yan C, Mizokami M, Tanaka Y, Jyoko K, Yamamoto K, Miyaoka H, Yamashita Y, Ohno N, Onji M. Comparison of genotypes C and D of the hepatitis B virus in Japan: a clinical and molecular biological study. J Med Virol 2004; 72: 551-557
20. Kim BJ, Song BC. Distribution of hepatitis B virus genotypes according to the clinical outcomes in patients with chronic hepatitis B virus infection in Jeju island. Korean J Gastroenterol 2003; 42: 496-501
21. Wang Y, Zhou G, Li X, Zhou Z, Zhou S, Ruan L, Chen M, Deng W. Genotyping of hepatitis B virus and clinical investigation Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002; 16: 367-369
22. Ding X, Mizokami M, Yao G, Xu B, Orito E, Ueda R, Nakanishi M. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001; 44: 43-47
23. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 118: 554-559
24. Yuen MF, Sablon E, Wong DK, Yuan HJ, Wong BC, Chan AO, Lai CL. Role of hepatitis B virus genotypes in chronic hepatitis B exacerbation. Clin Infect Dis 2003; 37: 593-597
25. Kato H, Orito E, Gish RG, Bzowej N, Newsom M, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M.Hepatitis B e antigen in sera from individuals infected with hepatitis B virus of genotype G. Hepatology 2002; 35: 922-929
26. Kao JH, Chen PJ, Lai MY, Chen DS.Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 2002; 40: 22-25
27. Kao JH, Chen PJ, Lai MY, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus. Hepatology 2001; 34: 817-823
28. Pramoolsinsup C. Management of viral hepatitis B. J Gastroenterol Hepatol 2002; 17 Suppl: S125-S145
29. Alberti A, Brunetto MR, Colombo M, Craxi A. Recent progress and new trends in the treatment of hepatitis B. J Med Virol 2002; 67: 458-462
30. Yuen MF, Wong DK, Sablon E, Yuan HJ, Sum SM, Hui CK, Chan AO, Wang BC, Lai CL. Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine. Antivir Ther 2003; 8: 531-534
31. Yuen MF, Tanaka Y, Lai CL. Hepatitis B genotypes in chronic hepatitis B and lamivudine therapy. Intervirology 2003; 46: 373-376
32. Akuta N, Suzuki F, Kobayashi M, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saituh S, Arase Y, Ikeda K, Kumada H. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. J Hepatol 2003; 38: 315-321